Status:
COMPLETED
Assessing the Symptoms of Obstructive Sleep Apnea
Lead Sponsor:
Bangor University
Conditions:
Obstructive Sleep Apnea
Eligibility:
MALE
18-70 years
Brief Summary
The purpose of this study is to investigate the correlation between health outcomes associated with the severity of obstructive sleep apnea (OSA) symptomatology, the findings will guide the design of ...
Detailed Description
Obstructive sleep apnea is a condition characterised by periods of narrowing of the pharyngeal airways during sleep causing hypoxic and hypercapnic episodes with the cessation of ventilation. Consider...
Eligibility Criteria
Inclusion
- Body Mass Index ≤39
- Not received any treatment for Obstructive Sleep Apnea.
- Is a non-smoker
- Is not epileptic
- Epworth Sleepiness Scale ≥ 10.
- Patient's on Statins or antihypertensive drugs are included as so frequent in OSA.
Exclusion
- Body Mass Index ≥ 39.
- Presence of significant or unstable Renal, Liver or Heart Failure.
- Receiving anti-diabetic treatment.
- Is a smoker.
- Is epileptic
- Presence of significant or unstable psychological morbidities.
Key Trial Info
Start Date :
November 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2014
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT01481636
Start Date
November 1 2011
End Date
June 1 2014
Last Update
June 17 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Betsi Cadwaladr University Health Board
Bangor, Gwynedd, United Kingdom, LL57 2PW